Loading...
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
The optimal treatment for schizoaffective disorder (SCA) is not well established. In this initial 6-month open-label treatment period of a large, multiphase, relapse-prevention study, the efficacy and safety of paliperidone palmitate once-monthly (PP1M) injectable were evaluated in subjects with sym...
Na minha lista:
| Udgivet i: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4932150/ https://ncbi.nlm.nih.gov/pubmed/27322760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000535 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|